SPONSOR
Hubei Cancer Hospital
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Breast NeoplasmsIschemia-Reperfusion InjuryPostoperative ComplicationsWound HealingOxidative StressInflammationElderly PatientsMetastatic Lung CancerBreast CancerImplant Breast Reconstruction
Clinical Trials by Hubei Cancer Hospital
NCT07263347
Recruiting
DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes
Breast Neoplasms
NCT06032052 Phase 2
Recruiting
Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients
Elderly Patients
NCT05992870
Recruiting
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology